IMED2007_Heymann.pdf - International Society for Infectious ...

More documents

Recommendations

Info

Accelerated campaign strategy, India, 2007 100% 90% 80% 70% 60% 50% 40% Closing immunity gap in the young mOPV1 rounds every 4 weeks & mOPV1 at birth IMMUNE 30% 20% 10% SUSCEPTIBLE 0% 0 to 4 5 to 8 8 to 12 13 to 16 17 to 20 21 to 24 25 to 28 29 to 32 33 to 36 Age range February 2007 World Health Organization 32
New Initiatives by Government of India New Manpower & Infrastructure: – 2200 more doctors (800 appointed) – 73,000 new ASHA workers (46,000 trained) New Strategies: – mOPV1 campaigns every month – mOPV1 birth dose (72% coverage in pilot areas) – IPV on limited basis in 1-2 rounds in late 2007 – mOPV3 used in intermittant localized campaigns Renewed Government Ownership and funding February 2007 World Health Organization 33
Page 1 and 2: Polio Eradication: completing the j
Page 3 and 4: Polio eradication: scientific basis
Page 5 and 6: World Health Assembly Resolution: p
Page 7 and 8: Reality: weak national immunization
Page 9 and 10: Reality: inability to sustain campa
Page 11 and 12: Virus linked to common ancestor, We
Page 13 and 14: AFP reporting rate world-wide, 2004
Page 15 and 16: Micro-planning and mapping for immu
Page 17 and 18: Polio eradication progress 1988 350
Page 19 and 20: Challenge: suspension of polio immu
Page 21 and 22: International spread of polio from
Page 23 and 24: International spread of polio from
Page 25 and 26: Change in laboratory algorithm: dec
Page 27 and 28: Number of children paralyzed, inter
Page 29 and 30: Polio in vaccinated children: high
Page 31 and 32: Monovalent oral polio vaccine: grea
Page 33 and 34: Poliovirus isolated from sewage, Eg
Page 35 and 36: Polio in reservoir areas 2007: loca
Page 37: and vaccine virus isolation dropped
Page 41 and 42: Immunization Plus Days, Nigeria 200
Page 43 and 44: Systematic engagement of Muslim soc
Page 45 and 46: Dilemma: circulating vaccinederived
Page 47 and 48: Vaccine derived polio viruses: defi
Page 49 and 50: Vaccine-associated risks to polio e
Page 51 and 52: Vaccine-associated and other risks
Page 53 and 54: Worldwide containment, wild poliovi
Page 55 and 56: Challenges for the polio eradicatio
Page 57 and 58: Challenge: Smallpox endemic in 31 c
Page 59 and 60: Simplified containment: smallpox er
Page 61 and 62: Smallpox eradication certified worl
Page 63 and 64: Persons living with HIV infection,

IMED2007_Heymann.pdf - International Society for Infectious ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?